Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/121126
Title: | Prevalence and effects of cigarette smoking, cannabis consumption, and co-use in adults from 15 countries with congenital heart disease |
Authors: | Moons, Philip Luyckx, Koen Kovacs, Adrienne H. Holbein, Christina E. Thomet, Corina Budts, Werner Enomoto, Junko Sluman, Maayke A. Yang, Hsiao-Ling Jackson, Jamie L. Khairy, Paul Cook, Stephen C. Chidambarathanu, Shanthi Alday, Luis Eriksen, Katrine Dellborg, Mikael Berghammer, Malin Johansson, Bengt Mackie, Andrew S. Menahem, Samuel Caruana, Maryanne Veldtman, Gruschen Soufi, Alexandra Fernandes, Susan M. White, Kamila Callus, Edward Kutty, Shelby Apers, Silke Grech, Victor E. Vella, Sheena Mifsud, Anabel Borg, Neville Chircop, Daniel Mercieca Balbi, Matthew Vella Critien, Rachel Farrugia, James Gatt, Yanika Muscat, Darlene |
Authors: | APPROACH-IS Consortium and ISACHD |
Keywords: | Tobacco use -- Health aspects Cannabis -- Health aspects Congenital heart disease -- Patients -- Attitudes Congenital heart disease -- Patients -- Psychological aspects Congenital heart disease -- Research -- International cooperation |
Issue Date: | 2019 |
Publisher: | Elsevier |
Citation: | Moons, P., Luyckx, K., Kovacs, A. H., Holbein, C. E., Thomet, C., Budts, W.,...Apers, S. (2019). Prevalence and effects of cigarette smoking, cannabis consumption, and co-use in adults from 15 countries with congenital heart disease. Canadian Journal of Cardiology, 35(12), 1842-1850. |
Abstract: | Background: The prevalence and effects of cigarette smoking and
cannabis use in persons with congenital heart disease (CHD) are poorly
understood. We (1) described the prevalence of cigarette smoking,
cannabis consumption, and co-use in adults with CHD; (2) investigated
intercountry differences; (3) tested the relative effects on physical
functioning, mental health, and quality of life (QOL); and (4) quantified
the differential effect of cigarette smoking, cannabis use, or co-use on
those outcomes. Methods: APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale-Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results: Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions: We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/121126 |
Appears in Collections: | Scholarly Works - FacM&SMed |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Prevalence and effects of cigarette smoking cannabis consumption and co use in adults from 15 countries with congenital heart disease 2019.pdf Restricted Access | 1.21 MB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.